News from the FDA/CDC

FDA authorizes Pfizer antiviral pill for COVID-19

Publish date: December 22, 2021

 

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

Medical board stops warning docs against giving false COVID information
MDedge Dermatology
Omicron may require fourth vaccine dose, Pfizer says
MDedge Dermatology
Major COVID-19 case growth expected in coming weeks
MDedge Dermatology
12 state boards have disciplined docs for COVID misinformation
MDedge Dermatology
COVID-19 asymptomatic infection rate remains high
MDedge Dermatology
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
MDedge Dermatology
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
MDedge Dermatology
COVID cases spike as questions remain about Omicron’s threat
MDedge Dermatology
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
MDedge Dermatology
Bamlanivimab’s effects in COVID-19 depend on antibodies
MDedge Dermatology